PALB2 mutations and prostate cancer risk and survival

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

(2021) Alicja Łukomska et al.   Cancers

Olaparib for Metastatic Castration-Resistant Prostate Cancer

(2020) Johann de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA

(2020) T. Grellety et al.   ANNALS OF ONCOLOGY

Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications

(2020) Andreia Brandão et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer

(2020) Burcu F Darst et al.   JNCI-Journal of the National Cancer Institute

Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China

(2019) Mei Deng et al.   INTERNATIONAL JOURNAL OF CANCER

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel

(2019) Daniel A. Leongamornlert et al.   EUROPEAN UROLOGY

The spectrum of mutations predisposing to familial breast cancer in Poland

(2019) Cezary Cybulski et al.   INTERNATIONAL JOURNAL OF CANCER

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

(2019) Elizabeth C. Page et al.   EUROPEAN UROLOGY

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

(2019) Xin Yang et al.   JOURNAL OF CLINICAL ONCOLOGY

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

(2018) Fredrick R. Schumacher et al.   NATURE GENETICS

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

(2017) Rong Na et al.   EUROPEAN UROLOGY

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

(2016) Marcin R. Lener et al.   INTERNATIONAL JOURNAL OF CANCER

Familial Risk and Heritability of Cancer Among Twins in Nordic Countries

(2016) Lorelei A. Mucci et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

PALB2,CHEK2andATMrare variants and cancer risk: data from COGS

(2016) Melissa C Southey et al.   JOURNAL OF MEDICAL GENETICS

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

(2016) Colin C. Pritchard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

(2015) Cezary Cybulski et al.   LANCET ONCOLOGY

Germline RECQL mutations are associated with breast cancer susceptibility

(2015) Cezary Cybulski et al.   NATURE GENETICS

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease

(2014) D Leongamornlert et al.   BRITISH JOURNAL OF CANCER

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Elevated Risk of Prostate Cancer Among Men With Lynch Syndrome

(2013) Victoria M. Raymond et al.   JOURNAL OF CLINICAL ONCOLOGY

An inherited NBN mutation is associated with poor prognosis prostate cancer

(2012) C Cybulski et al.   BRITISH JOURNAL OF CANCER

Germline Mutations inHOXB13and Prostate-Cancer Risk

(2012) Charles M. Ewing et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype

(2009) T. Heikkinen et al.   CLINICAL CANCER RESEARCH

PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

(2009) Feng Zhang et al.   CURRENT BIOLOGY

Analysis of the gene coding for the BRCA2-Interacting protein PALB2 in hereditary prostate cancer

(2008) Marc Tischkowitz et al.   PROSTATE